The decision comes as Schumer is now the Senate’s #2 recipient of pharmaceutical industry campaign cash.
By David Sirota, The Lever
Senate Majority Leader Chuck Schumer (D-N.Y.) let a U.S. Senate adviser kill key parts of Democrats’ promised drug pricing legislation, as Schumer has become the Senate’s second largest recipient of pharmaceutical industry cash.
On Saturday, the Senate’s parliamentary adviser Elizabeth MacDonough — who Schumer can remove — issued a non-binding advisory opinion saying Democrats should remove provisions in their spending bill that would punish drugmakers for inflating their prices for patients in private health insurance plans. The provision could have saved $40 billion, according to one estimate.
“The exclusion of the private insurance price limits means there is little left that will reduce costs for the vast majority of Americans who receive health insurance through their private sector employer,” reported Politico.
MacDonough also advised Democrats against including a provision in their legislation to cap out-of-pocket insulin costs at $35 a month for people on private insurance plans. Democrats ultimately held a failed vote to overrule her on the insulin cap.
Recent Posts
American Jews Are More Ambivalent About Israel Than Ever
Take Action Now Grappling with a far-right government and growing awareness of the Nakba, American Jews revealed mixed feelings marking…
Weapons Manufacturers Are Overjoyed About The Debt Ceiling Deal
Take Action Now Lockheed Martin’s James Taiclet called the bill ‘as good an outcome as our industry or our company could ask for.’……
Police Arrest Organizers Behind Cop City Protester Bail Fund
Take Action Now “There is no First Amendment in Atlanta,” wrote activist Micah Herskind. By Sharo n Zhang, truthout Law enforcement officers in…
Why There Should Be A Treaty Against The Use Of Weaponized Drones
Take Action Now “The military goods sold at CANSEC are used in wars, but also by security forces in the repression of human rights defenders, civil…